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Abstract 
AIDS is one of the most significant health care problems worldwide. Due to the difficulty and 
costs involved in treating HIV, preventing infection is of paramount importance in controlling the 
AIDS epidemic. The main purpose of this paper is to explore the potential of using Data 
Envelopment Analysis (DEA) to establish international comparisons on the efficiency of 
implementation of HIV prevention programmes. To do this we use data from 52 low- and middle-
income countries regarding the prevention of mother-to-child transmission of HIV. Our results 
indicate that there is a remarkable variation in the efficiency of prevention services across nations, 
suggesting that a better use of resources could lead to more and improved services, and ultimately, 
prevent the infection of thousands of children. These results also demonstrate the potential 
strategic role of DEA for the efficient and effective planning of scarce resources to fight the 
epidemic. 
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1. Introduction 
 
The epidemic caused by the human immunodeficiency virus (HIV) is currently 
one of the greatest public health problems worldwide. It is estimated that in 2009 
alone, 33.3 million people were living with HIV/AIDS, 2.6 million were newly 
infected with HIV and 1.8 million died from AIDS [1]. Although the majority of 
the disease burden remains in sub-Saharan Africa, the number of HIV-infected 
people is rapidly increasing in other regions, especially in Eastern Europe and 
Central Asia. 
 
Due to the difficulty and costs involved in treating HIV, preventing infection is of 
paramount importance in controlling the AIDS epidemic. In particular, effective 
prevention measures can reduce new infections, the incidence of the disease and, 
consequently, the number of people that will require treatment. Whilst appropriate 
prevention measures can change the course of the epidemic, they require very 
substantial resources. It is estimated that the average cost of preventing an 
infection is US $3,923 [2]. Given the limited resources available to healthcare 
systems in many of the most affected countries, the implementation of efficient 
and effective HIV prevention interventions is vital for policy makers and health 
care managers. It is therefore imperative to identify the most effective HIV 
prevention strategies as well as the most efficient ways of allocating the scarce 
resources available to these strategies.  
 
Resource allocation models have been developed over the years intended to assist 
with allocation strategies that might improve the overall effectiveness of HIV 
prevention efforts. For some recent examples, the reader is referred to Lasry et al. 
[3], Earnshaw et al. [4] and Brandeau et al. [5]. However, as pointed out by 
Rauner and Brandeau [6], determining how best to spend limited resources on 
HIV prevention programmes in different regions of the world is a challenging 
task. One way of overcoming this challenge and obtain useful information for 
decision making consists of identifying best practices that can be shared to 
promote improvements. Benchmarking exercises to identify best practices 
amongst health care providers within a country or across countries have the 
3 
potential to provide essential information for the improved allocation of HIV 
prevention funds. 
 
Identifying best practice is not, however, straightforward. Although some 
international comparisons have been carried out in recent years, the approaches 
adopted have tended to rely on two major types of analysis: one that focuses on 
specific interventions and compares the relative costs and benefits of a particular 
prevention programme against the other alternatives (e.g. Beck and Miner [7]; 
Harling et al. [8]), and another that focuses on data aggregated at the country level 
and uses multiple performance indicators to show the progress that is being made 
by each country towards HIV prevention (e.g. UNAIDS [1]). Whilst valuable, 
these approaches are limited in carrying out comparative analyses and identifying 
best practice. The former is strongly impacted by the range of prevention 
strategies and geographic settings examined, ignoring the fact that one 
intervention might not be efficient in some countries but be efficient in others. 
The latter does not usually account for the fact that some countries might be better 
than others when using certain indicators, while poorer using others, making it 
difficult to derive a single aggregate measure of the overall performance of each 
of these countries in fighting the HIV epidemic.  
 
The main purpose of this paper is to address these limitations by exploring the 
potential of using Data Envelopment Analysis (DEA) to establish international 
comparisons on the efficiency of HIV prevention, focusing on mother-to-child 
transmission, which is one of the strategies given high priority in battling the HIV 
epidemic.  For an overview of the most important types of HIV/AIDS prevention 
and treatment interventions, the reader is referred to Rauner and Brandeau [6]. 
Mother-to-child transmission occurs when an HIV positive woman passes the 
virus to her baby during pregnancy, labour and delivery, or by breastfeeding. It is 
estimated that without appropriate prevention and treatment, around 15 to 30 
percent of babies born to HIV positive women will contract HIV during 
pregnancy and delivery. A further 5 to 20 percent will become infected through 
breastfeeding [9]. It is, therefore, fundamental to ensure that mother-to-child- 
interventions which counsel and test pregnant women for HIV, offer antiretroviral 
medications to both the mother and infant to prevent HIV transmission, and  
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provide substitute feeding programmes to prevent transmission through 
breastfeeding, are as efficient and effective as possible. An efficient and effective 
use of resources in this particular context has the potential to save the lives of 
thousands of children each year. 
 
 
2. Assessing Efficiency of Mother-to-Child HIV 
Prevention  
 
In recent years, we have witnessed remarkable progress in the fight against the 
mother-to-child transmission of HIV, with the AIDS Annual Report [1] 
documenting a significant decrease in the infection rates among children born to 
mothers living with HIV. According to this report, in 2009, an estimated 370,000 
children contracted HIV during the perinatal and breastfeeding period, down from 
500,000 in 2001. Prevention of mother-to-child HIV transmission (PMTCT) has 
played a key role in this decrease. Unfortunately, however, this success has not 
been shared by all countries. Whilst in high-income countries mother-to-child 
HIV transmission has been virtually eliminated thanks to effective prevention and 
care, the number of children infected in low- and middle-income countries is still 
very high. This might be explained in part by the fact that coverage of antenatal 
care and other services for preventing mother-to-child transmission among 
women living with HIV varies considerably across nations. However, the fact that 
infection rates also vary considerably among low- and middle-income countries, 
seems to indicate that the resources allocated to prevention have been more 
efficiently and effectively used in some countries than in others. 
 
The need to use the resources allocated to HIV prevention efficiently can hardly 
be overstated. As emphasised by Appleby and Thomas [10] and Flessa [11], an 
inefficient use of resources in the health care context means not only that money 
is wasted, but more importantly that the opportunity is lost to save lives, avert 
pain, and provide care to those in need. The search for efficiency and 
effectiveness in the use of resources has been a key driving force for many of the 
OR/MS science applications in the health care sector and for the emergence of 
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important publications in this area (see, for example, Ozcan and Smith [12]).  
With this call for more efficiency and effectiveness in health care, a call for a 
further shift in the balance between prevention and treatment has also been made, 
with some authors acknowledging that OR/MS techniques have an important role 
to play in helping the shift towards more prevention (e.g. Royston [13]). Whilst 
these calls apply to all health care areas, they are particularly meaningful in the 
case of the HIV/AIDS epidemic. The Committee on HIV Prevention Strategies in 
the United States pointed out that decisions regarding the allocation of HIV 
prevention funds represent the single most important set of HIV prevention 
decisions made [14]. However, as emphasised by Kaplan and Merson [15: 1907] 
it is important to bear in mind that HIV “resource allocation is not simply an 
argument for how to divide the pie; some allocations are arguably better than 
others.”  
 
Considering that an efficient and effective allocation of resources is a key 
ingredient in controlling the HIV epidemic, and that there is some compelling 
evidence suggesting that the unit cost of HIV prevention programmes may be both 
higher and more variable than some estimates suggest (e.g. Marseille et al. [16]), 
it is fundamental for researchers to carry out comparative analyses across nations 
in order to identify best practices. The research we discuss in this paper aims to 
shed some light on this issue by comparing the resources spent by several 
countries on mother-to-child HIV prevention with the services provided.  
 
Although there is an increasing and highly relevant body of literature on the 
efficiency and/or effectiveness of specific prevention, treatment and care 
programmes (see for example, Harling et al. [8]), the number of studies assessing 
and comparing how efficiently different countries are using the available funds to 
combat the epidemic is very rare. Furthermore, when comparisons are made, these 
tend to rely on the use of multiple performance indicators or ratios rather than on  
a single aggregate measure of the overall performance of each country. This 
problem could be addressed if it was possible to reach an agreement on the 
relative importance of the various performance indicators. This is, however, 
seldom the case as the importance of each indicator is dependent upon the 
perspective taken and upon the priorities of the countries under evaluation. 
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Data envelopment analysis, developed by Charnes, Cooper and Rhodes in 1978  
[17] is a non-parametric linear programming technique which has proved very 
effective in addressing this limitation and it is one of the most important and 
widely used approaches to measure the performance of homogeneous decision 
making units (DMUs) performing the same task. This technique uses a production 
metaphor.  Each DMU is engaged in a transformation process, where by using 
some inputs (resources) it is trying to produce some outputs (goods or services). 
With the provision of these services the DMU achieves certain outcomes which 
measure the impact of the services on the users. One of the interesting features of 
DEA is that it allows each unit to identify a benchmarking group; that is, a group 
of units that are following the same objectives and priorities, but performing 
better. In this respect DEA aims to respect the priorities of each DMU by allowing 
each one of them to choose the weight structure for inputs and outputs that most 
benefits its evaluation. As a result, it aims to classify each unit in the best possible 
light in comparison to the other units.  
 
The formulation of the DEA problem, under variable returns to scale, with output 
orientation, for DMU 0, as proposed by Banker et al. [18] is as follows:   
 
φ Max   
Subject to: 
0
1
ij
n
j
ij XX ≤∑
=
λ  ( )mi ,...,1=  
0
1
j
n
j
jrj YY φλ ≥∑
=
 ( )sr ,...,1=  
1
1
=∑
=
n
j
jλ   
0≥jλ  ( )nj ,...,1=  
 
In this problem, n is the number of DMUs; s is the number of outputs and m is the 
number of inputs; Yr0 is the amount of output r generated by unit 0 and Xi0 is the 
amount of input i used by unit 0; jλ  
is the intensity variable for DMU j. The score  
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φ  obtained from the solution to this linear programming problem is the 
maximum rate of proportional expansion in all outputs of DMU 0, without 
decreasing its inputs. The efficiency rate of DMU 0 can be obtained by calculating 
1/ φ  , and will be equal to 1 if the DMU is efficient, and smaller than 1 if the 
DMU is inefficient when compared with the other DMUs. A comprehensive 
review of the DEA technique can be found in Cooper et al. [19, 20]. 
 
Since its advent in 1978, this method has been the subject of several theoretical 
developments and has been extensively applied in many sectors including 
education, finance, agriculture, sports, marketing and manufacturing, to name just 
a few. There have also been several documented applications of DEA in the health 
care sector. The Health Care Management Science journal, amongst others, has 
been an important forum for the dissemination of these applications. In two recent 
special issues of this journal dedicated to contemporary health care applications in 
OR/MS and to operational research applied to health services, the reader can find 
several good examples of DEA in this context (e.g. Ozgen and Ozcan [21]; 
O’Neill and Dexter [22]; and Langabeer and Ozcan [23]). Hollingsworth et al. 
[24], Hollingsworth [25], Chilingerian and Sherman [26] and more recently 
Hollingsworth [27], review several of the DEA applications in the health care 
context.  
 
Whilst the use of DEA in the health care sector has been prolific, to the best of our 
knowledge, no studies have been documented on the use of DEA comparing the 
efficiency of countries in using HIV prevention resources. The only exception to 
this is the study by Zanakis et al. [28], which examines the impact of major socio-
economic factors on HIV/AIDS indicators and assesses each country’s efficiency 
in battling the epidemic. In so doing, it makes an important contribution to this 
under researched area, not only because it is the first one using DEA to assess the 
efficiency of nations in battling HIV but also because it identifies that research on 
HIV/AIDS should include both individual and socio-economic factors, to better 
understand the development of the global epidemic.  
 
The research we discuss in this paper presents, however, some important 
departures from Zanakis et al.’s study. Firstly, the assessment of each country’s 
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efficiency in preventing HIV infections is the main focus and objective of our 
research. In Zanakis et al.’s study this objective was part of a broader agenda and 
played a fairly marginal role. Secondly, our study focuses exclusively on the 
efficiency of HIV prevention, whilst theirs does not seem to distinguish 
prevention from treatment.  However, our study, in line with the findings reported 
by Beck [29] and Piot et al. [30] acknowledges that the containment of the HIV 
epidemic requires a global strategy which combines effective prevention with 
treatment and care programmes. This implies that some variables related to HIV 
treatment and care will be considered in the analysis as they have a significant 
impact on HIV transmission. Thirdly, the model we propose is considerably 
different from the one they have used. In particular, we focus on a particular 
programme and use variables more directly related to HIV prevention than the 
surrogate general health variables used by Zanakis and colleagues. Finally, our 
study, by using data for 2008, aims to offer an updated overview of the efficiency 
of recent efforts in battling the epidemic whereas the analysis carried out by 
Zanakis et al. used data from 1998. Thus, our research complements this previous 
work and makes an important contribution to knowledge. Zanakis et al. 
recognised that their study was preliminary and that further additional multi-
country studies in global efficient strategies for combating HIV/AIDS were 
needed. As emphasised by Harling et al. [8], establishing multi-country 
comparative analyses on the use, cost and outcome of HIV prevention services, 
especially in middle and lower income countries, is critical to fill some of the 
large gaps which exist in the scientific literature on HIV interventions in these 
countries. These gaps have limited the ability for the existing literature to guide 
policy makers in those settings where the epidemic is most intense. As pointed out 
by Harling et al. [8: 372] “increased research in such settings and dissemination of 
their findings is urgently required, especially given the need for intensified 
prevention strategies to complement the scaling up of HIV treatment and care 
services in these countries.” 
 
The framework proposed to assess the efficiency of mother-to-child HIV 
prevention and to contribute to the extant literature, draws on the principles of the 
Prevent AIDS Network for Cost-Effectiveness Analysis (PANCEA) approach 
[16]. PANCEA is a five-country study, funded by the U.S. National Institute of 
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Health, aimed at providing information for an improved allocation of HIV 
prevention funds in low- and middle-income countries. In particular, the 
PANCEA approach is designed to generate three indicators of efficiency for each 
prevention programme: cost per unit of service provided, cost per reduction in 
risky behaviours, and cost per HIV infection prevented. Figure 1 illustrates how 
these indicators build on each other. 
 
 
 
 
 
 
 
 
 
 
 Source: Adapted from Marseille et al. [16]. 
 
Figure 1. The PANCEA Conceptual Framework 
 
 
The first indicator of efficiency measures the cost per unit of service provided by 
a particular programme or intervention (e.g. cost per pregnant woman who 
received voluntary counselling and testing). The second indicator of efficiency 
assesses the cost of reducing risky behaviours (e.g. cost per newly protected sex 
episode). The third indicator measures the cost effectiveness of the programme by 
comparing its costs with the outcomes achieved (e.g. cost per HIV infection 
averted).  
 
The analysis we discuss in this paper focuses essentially on the Efficiency of 
Services Provision regarding mother-to-child HIV prevention. In spite of its 
limited scope, it can provide essential information for an improved allocation of 
HIV prevention funds as there is compelling evidence showing that the three 
indicators above are strongly linked. In particular, behavioural evaluations have 
Inputs 
Costs of the HIV/AIDS Prevention Programme 
Outputs I 
Units of Service 
Outputs II 
Behaviour Change 
Outputs III 
Health Outcomes 
Efficiency of  
Services Production 
Efficiency of  
Risk Reduction 
Cost-effectiveness 
÷ ÷ ÷ 
= = = 
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shown that the more units of service provided the lower the risky behaviours tend 
to be. Epidemic modelling has shown, in turn, that a reduction in behavioural risk 
contributes to reducing HIV transmission. Therefore, it seems reasonable to 
assume that by comparing the efficiency of service provision across countries and 
identifying the best performers, we are able to identify those countries that are 
most likely using the resources in a more effective way. This is, however, the 
subject of further research. Given that our study focuses on the efficiency of 
nations in implementing a particular prevention programme whilst the PANCEA 
project focuses on the efficiency of particular programmes when compared with 
alternative interventions, we believe that these two approaches can, together, 
provide a richer understanding of efficiency in HIV prevention and, consequently, 
a better foundation for policy recommendations. 
 
 
3. Empirical Analysis 
 
3.1. The DEA Model 
 
The choice of appropriate input and output variables is a fundamental step in DEA 
analysis. Whilst several input indicators may be used in this context, the costs of 
running mother-to-child HIV prevention interventions is, perhaps, the most 
relevant. These costs are usually grouped into three major categories: personnel 
expenses (e.g. salaries and other compensation paid to the personnel involved in 
the prevention programme), other recurrent goods and services expenses (e.g. 
medicines, laboratory tests, supplies, office and administrative expenses, and 
utilities), and capital expenses (e.g. medical equipment, furniture, vehicles, 
computers, and buildings). In this research we use the variable “Prevention of 
mother-to-child HIV transmission domestic spending from public and 
international financing sources (million US$)” as the only controllable input.  
 
The resources allocated to PMTCT can have several uses as various interventions 
are usually developed as part of the core response to achieve this objective. The 
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choice of the most appropriate outputs should, therefore, aim to include in the 
DEA model those outputs thought to have the greatest potential to reduce mother-
to-child HIV transmission. Taking this principle into account, the model we 
propose has four main outputs, which follow.  
 
The first output variable in our model is the “Reported number of pregnant 
women tested for HIV”. As identified by the Joint United Nations Programme on 
HIV/AIDS [31], voluntary counselling and testing are an essential part of any 
PMTCT strategy. HIV testing is critical because pregnant women who do not 
know they are HIV positive cannot benefit from appropriate prevention 
interventions. The protective benefit of antiretroviral drugs is diminished when 
babies continue to be exposed to HIV through breastfeeding, therefore, HIV 
positive mothers are advised not to breastfeed whenever they have safe, affordable 
alternatives to breastfeeding. HIV testing and counselling also offer significant 
opportunities to provide important advice to HIV positive mothers on the risks 
and benefits of different infant feed options. This allows them to make better 
informed decisions about the most suitable options and, ultimately, contributes to 
lower mother-to-child HIV transmission. In addition, when testing is carried out 
and post-test counselling is given, valuable information and support is also passed 
to women not infected to ensure the avoidance of future infection.  
 
The second output variable is the “Number of pregnant women living with HIV 
who received antiretrovirals for preventing mother-to-child transmission”. The 
administration of antiretroviral drugs to pregnant women decreases the viral load 
in the mother and is highly effective at preventing mother-to-child transmission 
(see, for example, Bryson [32]). Pregnant women who are HIV positive are 
usually advised to begin antiretroviral treatment either immediately or after the 
first trimester. Under the 2010 World Health Organization guidelines, all HIV 
positive mothers identified during pregnancy should receive an extensive course 
of antiretroviral drugs to prevent mother-to-child transmission.  
 
In order to lower the risk of transmission even further and/or reduce HIV-related 
morbidity and mortality, it is important, that newborn babies who have been 
exposed to the virus, are also given a course of prophylactic treatment for the first 
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few days or weeks with antiretrovirals and/or co-trimoxazole, respectively. Co-
trimoxazole is a widely available antibiotic that substantially reduces HIV-related 
morbidity and mortality in both adults and children. As pointed out by Zachariah 
et al. [33: 686], “prophylaxis with co-trimoxazole is a recommended intervention 
of proven benefit that could serve not only as an initial step towards improving 
paediatric care in young children with limited access to antiretroviral treatment, 
but also as an important complement to antiretroviral therapy in resource-limited 
settings”. Marseille et al. [34] have also provided evidence, more than a decade 
ago, suggesting that the administration of antiretrovirals to mothers and babies 
just before and soon after birth has a major potential impact on reducing vertical 
HIV transmission. In order to account for these factors, we included in our DEA 
model the following output variables: “Reported number of infants born to 
women living with HIV receiving antiretrovirals for preventing mother-to-child 
transmission” (i.e. Output 3) and “Reported number of infants born to women 
living with HIV receiving co-trimoxazole prophylaxis within two months of birth” 
(i.e. Output 4).  
 
In a comparative analysis of countries battling the HIV/AIDS epidemic it is also 
important to bear in mind that there are socio-cultural, political and economic 
factors (i.e. exogenous conditions) not directly controllable by the prevention 
authorities that can explain differences in efficiency and ultimately help 
understand the development of the epidemic within each country. Consequently, it 
is important to include in the analysis nondiscretionary variables (inputs and/or 
outputs) that will assure comparable technologies. According to Quinn [35], to 
control AIDS, countries must not only promote changes in individual behaviour 
but also address socio-economic issues. In fact, considerable HIV/AIDS 
differences among nations have been attributed to exogenous conditions like 
nation’s wealth, migration from rural to urban areas, education, access to health 
services and drug use. For example, Zanakis et al. [28], in exploring the effects 
that socio-economic factors have on the development of the HIV/AIDS epidemic, 
found evidence that countries with lower population density that manage to 
provide better health system performance, per capita support and better media 
information, without necessarily higher GNP, are more likely to exhibit lower 
HIV/AIDS indicators.  
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In the particular case of mother-to-child HIV transmission, several factors 
including education, degree of urbanization and access to health services have 
also been shown to impact the capacity of families to comply with prevention 
programmes.  
 
It is acknowledged that good quality HIV/AIDS education and knowledge 
regarding mother-to-child-HIV transmission are fundamental to eliminating myths 
and misunderstandings, and to counter stigma and discrimination against pregnant 
women. It is likely that in countries with lower literacy rates, pregnant women 
will be less willing to carry out voluntary testing and counselling for HIV, which 
might result in poorer efficiency results when compared with nations with higher 
literacy rates. To account for this non-controllable factor, and allow fairer 
comparisons, we decided to include a proxy variable to capture the level of 
education in the population. We have used the variable “People aged 15 years and 
older who can, with understanding, both read and write a short simple statement 
on their everyday life (millions)”. This variable resulted from the product of the 
literacy rate of each country and the respective population aged 15 years and 
older.  
 
Easy access to health facilities is also an important motivator for mothers to 
adhere to prevention programmes. In particular, there is evidence suggesting that 
in rural areas health care facilities are less accessible, and therefore, that pregnant 
women living in these areas are at higher risk of not complying with PMTCT 
programmes (e.g. Jones et al. [36]). In order to account for this factor we have 
included in our DEA model the variable “People living in urban areas (millions)”. 
This is an important variable to consider as the degree of urbanization also seems 
to have a significant impact on awareness among pregnant women regarding 
AIDS, HIV transmission and prevention methods. As pointed out by Msellati 
[37], when referring to mothers’ access to PMTCT programmes in West Africa, 
the level of knowledge about the HIV/AIDS epidemic can be considered good in 
urban areas but worse in rural areas.  Increased awareness by pregnant women is 
important as it improves their compliance with programmes targeted at preventing 
mother-to-child HIV transmission.  
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In addition to the socio-economic factors previously discussed, it is also known 
that weak health infrastructures exacerbate the impacts of the HIV/AIDS 
epidemic. As suggested by Coovadia and Hadingham [38] one of the major 
reasons for the apparent ineffectiveness of global interventions in battling the 
HIV/AIDS epidemic is the structural weaknesses in the health systems of 
underdeveloped countries, which contribute to bottlenecks in the distribution and 
utilisation of funds. As pointed out by these authors, robust health care systems 
play a critical role in channelling globally recognised prevention and treatment 
best practice for the mitigation of HIV/AIDS. It is important to bear in mind that 
investment in health infrastructures and in health care professionals can improve 
care provision, not only through improved detection and monitoring of HIV 
positive people but also through treatment of co-morbidities and nutritional 
support (Little et al. [39]). In order to account for this factor we have used the 
proxy variable “Total health expenditure (million US$)”. This variable is the sum 
of public and private health expenditure and it covers the provision of health 
services (preventive and curative), family planning activities, nutrition activities 
and emergency aid.  
 
Finally, we decided to include a variable to account for political factors. There is 
evidence suggesting that political instability can undermine maternal and child 
health services (e.g. de Castella [40]) and compromise adherence to programmes 
targeted at preventing mother-to-child HIV transmission. Unstable governments 
tend to put HIV prevention at the bottom of their political agenda. In order to 
account for this factor and carry out a fairer comparison of countries, we have 
used the variable “Political stability and absence of violence/terrorism” as a non-
controllable input in our model. This variable is from the Worldwide Governance 
Indicators (Kaufmann et al., [41]) and it reflects the compilation of responses on 
the quality of governance given by a large number of enterprise, citizen and expert 
survey respondents in industrial and developing countries. Considering that this 
variable ranges from approximately -2.5 (weak) to 2.5 (strong) governance 
performance, a transformation was undertaken in order to ensure that no negative 
values were present. Following Ali and Seiford [42], this input was transformed 
using the following expression: ( ) cXXMinabsX ioijio ++=  
~
. In this 
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expression,  ioX
~
 is the transformed value for input i of DMU0 and Xij is the 
original value of input i for DMUj, Xio is the original value for input i of DMU0 
and c is a constant.  
 
In summary, the DEA model we propose to assess the efficiency of mother-to-
child-HIV transmission interventions and which was developed based on the 
literature review and on the discussion presented above, is the one presented in 
Table 1:  
 
Table 1: DEA model to assess efficiency of mother-to-child HIV transmission prevention 
 
Inputs Outputs 
Discretionary: 
• Input 1: Prevention of mother-to-child 
HIV transmission domestic spending from 
public and international financing sources 
(million US$). 
 
Non-discretionary: 
• Input 2: People aged 15 years and older 
who can, with understanding, both read 
and write a short simple statement on their 
everyday life (millions); 
• Input 3: People living in urban areas 
(millions); 
• Input 4: Total health expenditure (million 
US$); 
• Input 5: Political stability and absence of 
violence/terrorism. 
• Output 1: Reported number of pregnant 
women tested for HIV; 
• Output 2: Number of pregnant women 
living with HIV who received 
antiretrovirals for preventing mother-to-
child transmission; 
• Output 3: Reported number of infants 
born to women living with HIV receiving 
antiretrovirals for preventing mother-to-
child transmission; 
• Output 4: Reported number of infants 
born to women living with HIV receiving 
co-trimoxazole prophylaxis within two 
months of birth. 
 
 
It is important to point out that a sequential production process may be in place 
here, rather than a simultaneous one, given that women must first be tested, and 
only afterwards can the other services be offered. However, considering that the 
available data does not allow distinction between the money that is spent on 
testing and that spent on targeted medication, it is important to include both types 
of outputs in the model. The DEA assumption of trade-offs between the output 
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variables is still applicable in this context, as certain countries may choose, at 
first, to spend most of the money on developing programmes to reach women for 
opportunistic testing. Other countries, which may already have in place effective 
testing programmes may choose to spend more money on providing targeted 
medication. In the future, if disaggregated data is available regarding the resources 
used for HIV testing and the resources used for targeted medication, it may be 
interesting to analyse the efficiency of each of these production stages as well as 
the effectiveness of the programmes in order to assess the impact of the services 
delivered.  
 
3.2. Data and Efficiency Results 
 
The data used in this study refers to the activity of 52 low- and middle-income 
countries regarding mother-to-child HIV prevention in 2008. As previously 
discussed, PMTCT programmes in developed countries have almost eliminated 
vertical HIV transmission. However, progress in low- and middle-income 
countries has been slow, and therefore, it is fundamental to compare prevention 
programmes in these countries in order to identify best practice. Whilst lack of 
availability of data prevented us from considering all low- and middle-income 
countries in the analysis, we believe that the 52 nations assessed are reflective of 
the problems faced by many other low- and middle-income countries worldwide 
regarding mother-to-child HIV prevention. Our sample includes countries 
belonging to various geographic regions. In particular, it includes 27 countries 
from sub-Saharan Africa, 6 from East, South and South-East Asia, 9 from Europe 
and Central Asia and 10 from Latin America and the Caribbean. Of these, 28 are 
low-income countries and 24 are middle-income countries. Our sample also 
includes countries with various HIV epidemic levels. In 26 of the countries 
assessed the epidemic is considered concentrated, in 22 it is considered 
generalised and in 4 it is considered low.  
 
The data used in our analysis was collected from a variety of international public 
sources including the Joint United Nations Program for HIV/AIDS, United 
Nations Development Program, World Health Organization and World Bank. 
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Although these are trustworthy sources, some of the information they provide is 
supplied by each individual country. Considering that some of these countries 
have very poor statistics, the analysis that follows has to be interpreted with 
caution.  
 
Table 2 presents a descriptive summary of the data for the 52 countries considered 
in the analysis. 
 
Table 2 - Summary statistics for the variables used in the study 
 
 
Spending 
in 
prevention 
(106 US$) 
Literate 
population 
(millions) 
Urban 
population 
(millions) 
Spending in 
health care  
(106 US$) 
Political 
stability 
index 
Pregnant 
women 
tested 
Pregnant 
women that 
received 
antiretrovirals 
Infants that 
received 
antiretrovirals 
Infants that 
received 
prophylactic 
treatment 
Input 1 Input 2 Input 3 Input 4 Input 5 Output 1 Output 2 Output 3 Output 4 
Low-income countries        
    Average 2.59 29.29 19.80 2959.79 1.39 340155 7486 5404 1643 
    St Dev 5.97 103.50 63.68 10167.21 0.78 793671 14925 10844 4270 
    Max 29.33 551.00 336.75 53485.00 2.42 4234401 59601 41253 21841 
    Min 0.00 0.08 0.10 15.00 0.01 6281 15 11 0 
Middle-income countries        
    Average 2.75 30.28 28.77 24007.08 1.68 361629 2635 2379 947 
    St Dev 3.47 45.48 44.03 49086.92 0.61 553201 3742 3465 2271 
    Max 13.90 157.71 163.92 195414.00 3.01 2381280 11971 10308 8315 
    Min 0.00 0.35 0.26 124.00 0.24 5335 6 0 0 
Total     
    Average 2.67 29.74 23.94 12674.92 1.52 350066 5247 4008 1322 
    St Dev 4.93 81.27 55.15 35406.58 0.71 686742 11411 8366 3479 
    Max 29.33 551.00 336.75 195414.00 3.01 4234401 59601 41253 21841 
    Min 0.001 0.08 0.10 15 0.01 5335 6 0 0 
 
 
From this table, one can see that there are considerable discrepancies across 
countries. For example, whilst the average spending on prevention of mother-to-
child HIV transmission is approximately US$2.7 million per country, some have 
spent considerably more than others. For instance, Sao Tome and Principe reports 
the lowest annual spending on this prevention programme (US$1,035), whilst 
Kenya the highest (US$29.3 million). From another angle, we can see that the 
estimated number of people aged 15 years and older who can, with understanding, 
both read and write is also highly variable between nations. This is explained in 
part by the fact that some countries like India are highly populated compared to 
other, small, countries (e.g. Sao Tome and Principle). Total health expenditure, 
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political stability and urbanization are also highly variable as can be seen from 
Table 2.  
 
Considering that there are remarkable discrepancies at the level of the inputs, it is 
not surprising that these will also exist at the outputs level. As shown in Table 2, 
the number of pregnant women tested for HIV and the number found to be HIV-
positive and receiving antiretroviral therapy also varies considerably among the 
52 nations in our sample. The same applies to the number of infants receiving 
antiretrovirals and/or co-trimoxazole. In this particular case, it is important to 
mention that the zero value, shown as the minimum, indicates that the countries 
are not providing these medicines to infants or, most likely, that data were not 
reported, and therefore, it was assumed as being zero. Given that there is no 
consensus in the DEA literature on how best to handle the issue of missing data, 
that the model we propose has several outputs, and that no weight restrictions are 
imposed on the outputs, we decided to adopt the approach proposed by 
Kuosmanen [43], who suggests replacing missing outputs by zero. This ensures 
that countries with no data available do not benefit in the performance assessment 
in relation to their counterparts. Furthermore, this approach does not bias the 
calculation of the efficient frontier as long as the countries with the missing data 
are inefficient, even if these data had been reported correctly. However, this 
approach, like alternative approaches, also has its own limitations. In particular, in 
can impact the DEA results in two ways. Firstly, it may bias the efficient frontier 
if the countries with the missing data would have been efficient had the missing 
data been reported correctly. Secondly, it may bias the efficiency scores for the 
countries who fail to report the data, because it may make them appear less 
efficient than they actually are.  
 
In order to assess each nation’s efficiency, we have used the PIM DEA software 
[44] and a DEA model with output orientation. This is justified by reasoning that 
countries should aim to increase the level of service provision, given spending on 
prevention and in health care in general, the population’s education, the degree of 
urbanization and the level of political stability observed. Furthermore, we have 
used an assumption of variable returns to scale (VRS), as proposed by Banker et 
al. [18]. According to Marseille et al. [45] the assumption of constant unit costs in 
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the context of HIV prevention may result in substantial inaccuracies as they found 
compelling evidence that efficiency increased (unit costs decreased) with scale, 
across all countries and interventions examined. Brandeau et al. [5] and Brandeau 
and Zaric [46], also discuss the issue of scale in HIV prevention programmes, 
pointing out that the relationship between investment in HIV prevention and HIV 
infections averted may not be linear, which indicates that increased spending on a 
prevention programme may not always be cost effective. Our choice of a VRS 
assumption is also consistent with the publication of Hollingsworth and Smith 
[47], which warns that when ratios are used, as is the case of the variable political 
stability, the BCC formulation [18] should be adopted. We have also used a 
weight restriction on the input side, in order to prevent countries from attributing a 
null weight to the variable related to spending on PMTCT. This restriction 
imposes that the sum of the virtual weights given by each country to the non-
controllable inputs cannot exceed the virtual weight given to the controllable 
input. The development of this virtual weight restriction follows the approach 
proposed by Sarrico and Dyson [48]. Please refer to the appendix for more details 
on the DEA model used. 
 
Table 3 presents the preliminary results from the DEA model discussed above. It 
presents the efficiency scores for each one of the 52 countries during 2008 as well 
as the returns to scale for each country. 
 
Due to the exploratory nature of this research and the limitations of the data, 
caution needs to be taken when we analyse these results. In spite of this, the 
results shown on Table 3 corroborate some previous findings reported in the 
literature and highlight some relevant aspects about the efficiency of each country 
in preventing mother-to-child HIV transmissions. 
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Table 3: Countries efficiency scores for 2008 
 
Technical 
Efficiency 
(%) 
Pure Technical 
Efficiency 
(%) 
Scale 
Efficiency 
(%) 
Returns to 
Scale 
 
Low-income countries 
    
      Benin 83.15 85.46 97.30 DRS 
      Burkina Faso 70.54 89.46 78.85 DRS 
      Burundi 30.6 76.62 39.94 IRS 
      Cambodia 39.64 51.91 76.36 DRS 
      Central African Republic 100 100 100.00 CRS 
      Chad 95.53 100 95.53 IRS 
      Congo 20.35 20.37 99.90 DRS 
      Côte d'Ivoire 100 100 100.00 CRS 
      Democratic Republic of the 100 100 100.00 CRS 
      Eritrea 100 100 100.00 CRS 
      Ghana 49.85 87.23 57.15 DRS 
      Guinea-Bissau 27.3 28.48 95.86 IRS 
      India 100 100 100.00 CRS 
      Kenya 100 100 100.00 CRS 
      Kyrgyzstan 100 100 100.00 CRS 
      Madagascar 100 100 100.00 CRS 
      Malawi 100 100 100.00 CRS 
      Mali 100 100 100.00 CRS 
      Mozambique 100 100 100.00 CRS 
      Myanmar 58.46 67.94 86.05 DRS 
      Niger 100 100 100.00 CRS 
      Nigeria 100 100 100.00 CRS 
      Rwanda 100 100 100.00 CRS 
      Sao Tome and Principe 100 100 100.00 CRS 
      Senegal 38.04 51.65 73.65 DRS 
      Tajikistan 21.86 26.55 82.34 DRS 
      Togo 58.82 60.04 97.97 IRS 
      Viet Nam 29.38 45.65 64.36 DRS 
     
Middle-income countries* 
    
      Angola 27.74 36.36 76.29 DRS 
      Argentina 37.01 60.01 61.67 DRS 
      Armenia 23.76 27 88.00 DRS 
      Azerbaijan 48.68 71.39 68.19 DRS 
      Belarus 27.86 47.47 58.69 DRS 
      Bolivia (Plurinational State of) 13.17 18 73.17 DRS 
      Botswana 100 100 100.00 CRS 
      Brazil 68.8 100 68.80 DRS 
      Cameroon 100 100 100.00 CRS 
      Chile 16.33 27.85 58.64 DRS 
      Colombia 39.8 43.7 91.08 DRS 
      El Salvador 26.37 43.59 60.50 DRS 
      Equatorial Guinea 66.11 71.25 92.79 IRS 
      Georgia 32.94 35.16 93.69 DRS 
      Honduras 36.02 48.8 73.81 DRS 
      Indonesia 56.73 100 56.73 IRS 
      Lesotho 100 100 100.00 CRS 
      Mexico 22.57 35.38 63.79 DRS 
      Paraguay 31.1 33.08 94.01 DRS 
      Peru 43.62 79.19 55.08 DRS 
      Republic of Moldova 36.5 36.66 99.56 DRS 
      Russian Federation 41.86 62.17 67.33 DRS 
      Thailand 77.64 100 77.64 DRS 
      Ukraine 49.46 69 71.68 DRS 
     
Average 62.5 71.9 84.5 
 
St Dev 32.0 29.0 17.1 
 
Max 100.0 100.0 100.0 
 
Min 13.2 18.0 39.9 
 
 Note: IRS=increasing returns to scale; CRS=constant returns to scale; DRS=decreasing returns to scale. 
*Includes lower-middle income and upper-middle income countries. 
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As can be seen from Table 3, we have broken down the technical efficiency score 
into pure technical efficiency and scale efficiency. In 2008, the average total 
efficiency score of the 52 countries was only 62.5%, with a standard deviation of 
approximately 32.0%, which indicates that there are considerable differences 
between countries and remarkable potential for improvement in some of them. In 
our study, the spending on preventing vertical transmission of HIV is classified 
CRS efficient in eighteen countries: Botswana, Cameroon, Central African 
Republic, Côte d’Ivoire, Democratic Republic of the Congo, Eritrea, India, 
Kenya, Kyrgyzstan, Lesotho, Madagascar, Malawi, Mali, Mozambique, Niger, 
Nigeria, Rwanda and Sao Tome and Principe. When we allow VRS, which seems 
to be a more appropriate assumption to adopt in this context, as explained 
previously, the average efficiency score increases to 71.9% and the number of 
efficient countries increases to twenty two. This means that we have only four 
countries (Brazil, Chad, Indonesia and Thailand) that are technically efficient 
while operating under sub-optimal scale sizes. Chad and Indonesia seem to 
operate under increasing returns to scale (IRS), which suggests that a bigger scale 
of operation would lead to a greater ratio of outputs over inputs. Brazil and 
Thailand seem to operate under decreasing returns to scale (DRS). In fact, with 
regard to most of the countries that are technically inefficient, the DEA results 
suggest that they operate under DRS, indicating that they could benefit from 
decreasing their size of operation. These results seem to counter the findings of 
Marseille et al. [45], who found evidence that efficiency increased with scale. The 
only countries which could benefit from operating at a higher scale are, according 
to the results in Table 3, Burundi, Chad, Equatorial Guinea, Guinea-Bissau, 
Indonesia and Togo. Whilst scale seems to play an important role in the efficiency 
of some countries (e.g. Burundi, Ghana, Indonesia and Thailand), others (e.g. 
Benin, Congo, Georgia, Guinea-Bissau, Republic of Moldova and Togo) could 
benefit mostly from a better use of the resources allocated to preventing mother-
to-child HIV transmission, whilst maintaining their size of operation.  
 
In analysing the efficiency results it is also important to identify the optimal 
weight structure chosen by each country. Despite the fact that the DEA model 
may yield alternative optimal solutions for the weights of the countries classified 
as efficient (Cooper et al. [49]), the different optimal weights identified can 
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provide useful information. For instance, the different optimal output weight 
profiles are useful to identify different service delivery strategies. Table 4 
illustrates some of these different strategies. 
 
 
Table 4: Virtual weights attributed to the variables by some of the countries (%) 
 
 
Spending 
in 
prevention 
(106 US$) 
Literate 
population 
(millions) 
Urban 
population 
(millions) 
Spending 
in health 
care 
(106 US$) 
Political 
stability 
index 
Pregnant 
women 
tested 
Pregnant 
women 
that 
received 
antiretro-
virals 
Infants 
that 
received 
antiretro-
virals 
Infants 
that 
received 
prophy-
lactic 
treatment 
 
Input 1 Input 2 Input 3 Input 4 Input 5 Output 1 Output 2 Output 3 Output 4 
Azerbaijan 50.0 0.0 50.0 0.0 0.0 99.9 0.0 0.0 0.1 
Belarus 50.0 42.6 7.4 0.0 0.0 98.4 0.0 0.0 1.6 
Botswana 50.0 38.7 3.8 3.8 3.8 4.0 4.0 67.5 24.6 
Brazil 50.0 50.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 
Cameroon 50.0 12.5 12.5 12.5 12.5 21.7 14.4 14.4 49.6 
Cambodia 50.0 0.0 50.0 0.0 0.0 97.5 0.0 2.5 0 
Côte d’Ivoire 50.0 0.0 0.0 0.0 50.0 27.7 72.3 0.0 0.0 
Chile 50.0 28.7 21.3 0.0 0.0 100.0 0.0 0.0 0.0 
El Salvador 50.0 31.0 19.0 0.0 0.0 100.0 0.0 0.0 0.0 
Equatorial Guinea 75.4 0.0 24.6 0.0 0.0 0.0 100.0 0.0 0.0 
Ghana 50.0 39.7 0.0 10.3 0.0 100.0 0.0 0.0 0.0 
Guinea-Bissau 50.0 13.8 0.0 10.9 25.3 56.5 43.5 0.0 0.0 
Honduras 53.0 23.0 24.0 0.0 0.0 100.0 0.0 0.0 0.0 
India 50.0 12.5 12.5 12.5 12.5 50.0 16.7 16.7 16.7 
Indonesia 50.0 1.4 1.4 13.1 34.1 25.0 25.0 25.0 25.0 
Kenya 50.0 5.9 5.9 5.9 32.2 66.3 6.2 21.2 6.2 
Madagascar 50.0 0.0 0.0 1.3 48.7 100.0 0.0 0.0 0.0 
Malawi 50.0 12.5 12.5 12.5 12.5 14.6 14.6 14.6 56.2 
Mali 63.7 35.3 0.3 0.3 0.3 0.3 0.3 0.3 99.0 
Mozambique 50.0 0.0 0.0 0.0 50.0 0.0 0.0 100.0 0.0 
Nigeria 50.0 12.5 12.5 12.5 12.5 29.5 8.4 32.0 30.2 
Sao Tome and 
Principe 
50.0 12.5 12.5 12.5 12.5 25.0 25.0 25.0 25.0 
Senegal 50.0 50.0 0.0 0.0 0.0 100.0 100.0 100.0 100.0 
Togo 55.8 1.0 0.0 43.2 0.0 2.2 0.0 97.8 0.0 
 
Average from the 52 
 
50.9 
 
16.5 
 
17.0 
 
7.3 
 
8.3 
 
68.9 
 
8.2 
 
14.3 
 
8.6 
St. Dev from the 52 4.0 15.7 17.8 10.7 12.5 37.5 18.6 26.0 18.1 
Max from the 52 75.4 50.0 50.0 50.0 50.0 100.0 100.0 100.0 99.0 
Min from the 52 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Note: The input weights of the countries classified as inefficient have been standardised to add to 100%, in order to allow 
for easier interpretation. 
 
As shown in Table 4, several different output weight profiles can be identified. 
Whilst some countries placed all the output weight in one of the outputs (e.g. 
Brazil, Equatorial Guinea, Mozambique), other countries distributed the weights 
between several or all outputs (e.g. Botswana, Cameroon, Kenya, Nigeria). The 
analysis of the results for the 52 countries shows that a large number of countries 
(i.e. 18 countries) have placed all the output weight on the output variable: 
“Reported number of pregnant women tested for HIV”. Brazil and Madagascar 
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are two examples of these countries: they have been classified as efficient, and 
placed 100% of the output weight on this output. A minority of countries also 
present an unbalanced profile of output weights, by placing all their weight on one 
of the other three outputs. For example, whilst Equatorial Guinea has put all its 
output weight on the variable “Number of pregnant women living with HIV who 
received antiretrovirals for preventing mother-to-child transmission”, 
Mozambique has placed all its output weight on the variable “Reported number of 
infants born to women living with HIV receiving antiretrovirals for preventing 
mother-to-child transmission”. Contrasting with this, we find four countries 
classified as efficient (Central African Republic, Chad, Indonesia and Sao Tome 
and Principe) that present a totally balanced weight profile regarding service 
provision, giving 25% of the weight to each output. The remaining countries 
present weights unequally distributed between two, three or all outputs.  
 
Table 4 shows that different input weight profiles can also be identified. At this 
stage it is important to recall that virtual weight restrictions were imposed to 
prevent countries from attributing less than 50% of the total input weight to the 
total spending on prevention of HIV transmission from mother-to-child. It is 
possible to verify that the weight attributed to this input varies between 50% and 
75.4%, with the large majority of countries attributing the minimum weight 
required. The remaining part of the input weight is distributed between the four 
environmental variables which account for socio-cultural, political and economic 
factors. In this respect, it is possible to find different weight profiles within these 
environmental variables, suggesting that some countries share some socio-
cultural, political or economic commonalities. For example, Cameroon, India, 
Malawi, Nigeria, and San Tome and Principe distribute the environmental input 
weight evenly between the four variables. Opposite to this, some countries place 
all their environmental weight on a single variable. For example, Senegal and 
Brazil place all their environmental weight on the input capturing the literacy rate, 
whilst Azerbaijan and Cambodia place all their environmental weight on the 
number of people living in urban areas. As expected, countries with considerable 
social and political unrest, such as Chad, Democratic Republic of Congo, Côte 
d’Ivoire, Central African Republic and Colombia, place a considerable amount of 
weight on the input capturing this aspect. 
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Another interesting piece of information provided by DEA relates to the 
identification of benchmarks for each of the inefficient countries. Benchmarks are 
units that are classified as efficient when applying the optimal weight structure of 
the inefficient units under analysis. For example, as illustrated on Table 5, 
Honduras and El Salvador, two neighbouring countries who share several socio-
cultural and economic commonalities, have similar sets of benchmarks for 
learning. These two countries were classified with below average efficiency rates 
suggesting great potential for improvement in this context. On one side, Honduras 
achieved 48.8% in terms of pure technical efficiency and its benchmarks for 
learning are Côte d’Ivoire, Niger, Madagascar and Malawi. On the other side, El 
Salvador achieved 43.59% in terms of pure technical efficiency and its 
benchmarks for learning are Côte d’Ivoire, Niger and Madagascar. In developing 
their strategies, policies and programmes for HIV prevention, Honduras and El 
Salvador can get inspiration from the policies and strategies developed by Côte 
d’Ivoire, Niger and Madagascar. These countries were identified as benchmarks 
for Honduras and El Salvador because they share commonalities in their social 
and economic structures, suggesting that similar policies can be effective in 
fighting vertical transmission of HIV. Honduras and El Salvador are two countries 
characterised by a high percentage of the population living in rural areas, below 
average literacy rates, low rates of contraception usage and high rates of teenage 
pregnancies, combined with fragmented, inefficient and inequitable health care 
systems which limit the access to services (World Health Organization [50, 51]). 
With specific relevance to the context of HIV prevention is the fact that these two 
countries have low coverage of family planning and low pre-natal, childbirth and 
post-natal care, as well as deficient training in public health, resulting in low 
levels of maternal education (World Health Organization [50, 51]).  If we inspect 
the optimal input weight structure of Honduras and El Salvador, we can confirm 
that these two countries distribute all their environmental weight between the 
variable capturing literacy rate and the variable measuring urban population. From 
another side, if we inspect the output weight structure of these countries, we 
conclude that all the output weight was put on the number of women tested for 
HIV. This means that, even with deficient coverage, this is the service in which 
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these countries appear to be focusing. Their relative performance in terms of the 
other three outputs (related with access to targeted medication) is even worse.  
 
If we inspect the strategies, policies and programmes developed by their 
benchmark countries, we can get inspiration for improvement in Honduras and El 
Salvador HIV prevention systems. Côte d’Ivoire, Niger and Madagascar (the three 
common countries which are benchmarks for Honduras and El Salvador) are also 
characterised by a high level of rural population and low literacy rate, resulting in 
challenges regarding access to ante-natal care (World Health Organization [52]). 
However, these three countries have developed inspiring policies and programmes 
to address these challenges. Due to the effectiveness of these programmes, steady 
progress has been achieved in terms of PMTCT (especially in terms of HIV 
testing). These good results allowed them to be identified by our DEA model as 
robust best practice examples. These policies and programmes have in common 
the focus on improving health coverage through the involvement of several actors 
in the health sector and the community. In these countries, innovative 
programmes were developed to address existing inequalities in access to services, 
such as the ‘mother and child health week’ introduced in Madagascar in October 
2007 which provides an opportunity for female HIV testing throughout the 
country (UNICEF [53]). Examples of other strategies and innovative programmes 
are discussed in detail in the next section.  
 
In addition to the information regarding the benchmarks from which the 
inefficient countries can learn, Table 5 also provides useful information to define 
the targets to be achieved by these countries. This information is contained in the 
lambda values displayed in each of the rows of Table 5.  For example, the values 
of the lambdas associated with El Salvador (i.e. 0.382, 0.468 and 0.15) represent 
the proportion of the service levels of Cote d’Ivoire, Madagascar and Niger that El 
Salvador is required to achieve to become efficient.  
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Table 5: Peers and lambdas for some countries  
 
 
Brazil Cameroon 
Côte 
d'Ivoire 
India Madagascar Malawi Mozambique Niger 
Sao 
Tome 
and 
Principe 
Thailand 
Angola 0.017 
  
  0.91 0.073    
Benin 
 
0.166 0.008  0.056   0.77   
Burkina Faso 
  
0.266   0.115  0.62   
Chile 0.112 
 
0.223  0.665      
El Salvador 
  
0.382  0.468   0.15   
Equatorial Guinea 
  
0.013   0.019   0.968  
Ghana 
  
0.884 0.017 0.099      
Honduras 
  
0.128  0.046 0.3  0.526   
Mexico 0.8 0.154 
 
0.046      0.223 
Senegal 
  
0.868     0.132   
Vietnam 
   
0.056 0.369     0.575 
    
       
Number of times 
country i is used 
as a peer 
9 14 12 9 17 11 2 10 6 3 
 
Whilst some countries serve as benchmarks for a large number of countries, 
others are classified as efficient but do not serve as a reference for other countries. 
From the 52 countries compared, Botswana, Chad, Democratic Republic of the 
Congo, Indonesia, Kenya, Lesotho, Mali, Nigeria and Rwanda have been 
classified as efficient but do not serve as references to any other country. These 
countries have chosen very peculiar weight structures, which means that they have 
been classified as efficient because there are no other countries to which they can 
be compared. In contrast, as presented in Table 5, there are five countries that 
serve as benchmarks to 10 or more countries, presenting robust efficiency status. 
These countries are: Madagascar, Cameroon, Côte d’Ivoire, Malawi and Niger. 
These results indicate that the policies and service delivery strategies used by 
these countries should be identified in order to provide guidance for other 
countries. We will now discuss some of these strategies.  
 
 
3.3. The practical and policy implications of the results 
Despite the exploratory nature of this research and data limitations, some 
important lessons can be derived from the results previously discussed. In 
particular, the results highlight that there is considerable potential to save the lives 
of thousands of children each year by improving PMTCT services across 
countries. In addition, the results constitute a valuable source of information to 
27 
policy makers, programme planners, managers, and implementers. By identifying 
best practices, the study points out those countries whose HIV prevention 
strategies ought to be investigated in order to develop sound strategies that can be 
replicated in those nations where HIV prevention strategies have been less 
successful.  
 
Two of the countries that represent important learning peers for other nations are 
Cameroon and Côte D’Ivoire. These countries have been previously identified as 
important best practices in the area of PMTCT (Family Health International [54], 
Welty et al. [55]) and some of their service delivery strategies have been 
documented (Bolu et al. [56]). According to our results, together, these two 
countries serve as benchmarks to more than 20 of the nations assessed. 
Considering that the prevention programmes followed by these two countries have 
proven their effectiveness in battling HIV transmission from mothers to their 
infants, we believe that useful insights can be derived from their analysis.  
 
Cameroon, which the DEA results indicate to be a benchmark to nations like 
Benin, Congo and Togo, can be an important example and inspiring model to 
these countries on how to reduce the incidence of HIV infection in children by 
involving the community in the scaling up of PMTCT services across the 
countries, including rural areas. By adopting a bottom-up approach Cameroon 
ensured the full involvement of the community and increased consensus, 
ownership and commitment towards successful PMTCT implementation. As 
identified by the AWARE-HIV/AIDS Project (Family Health International [54]), 
the success achieved by Cameroon is due, however, to several interrelated and 
complementary strategies. One of these strategies consists of using trained 
volunteers as community educators to help disseminate information regarding 
HIV/AIDS. This community education has been found to be an important 
forerunner of PMTCT as it is easier to provide counselling and testing to women 
who are knowledgeable about HIV/AIDS. Another important strategy adopted by 
the Cameroonian health authorities consists of the training of health workers in 
order to allow integration of PMTCT services in routine ante-natal care. This 
strategy, together with voluntary HIV counselling, an opt-out approach to HIV 
testing, and same day results for pregnant women in antenatal care, have 
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significantly increased the number of those who carry out the tests and who 
receive their results. This has proved fundamental in discovering the HIV status of 
pregnant women and assisting health care authorities to provide appropriate care 
to HIV-positive women and their newborns. The provision of antiretroviral 
therapy to HIV-positive pregnant women and the provision of counselling on 
infant feeding have proved critical to reduce the risk of mother-to-child 
transmission of HIV. Another strategy which has been fundamental in battling 
HIV transmission from mothers to children consists of involving local 
communities in  service delivery through ‘trained birth attendants’ and through 
support groups involving HIV infected women (Wanyu [57]). This strategy has 
been particularly valuable and effective in the scaling up of PMTCT, by allowing 
psychosocial support and infant feeding counselling to reach more women in 
need. 
 
These strategies have proved very effective in Cameroon, and therefore, we 
believe that their dissemination and replication in other countries could help them 
improve the efficiency and effectiveness of their prevention policies (see, for 
example, Msellati [31], Bolu et al. [56]). However, as demonstrated by the 
experience of Cameroon, for these strategies to produce the intended results it is 
fundamental that a clear and strong political leadership commitment exists to fight 
against HIV/AIDS. Furthermore, PMTCT needs to be seen as a major priority. 
Unless strong and available leadership gets involved early enough in the 
coordination of the implementation process, supervises the efforts on the ground 
through regular and effective monitoring and evaluation of PMTCT activities, and 
ensures the quality of the services provided, the strategies discussed previously 
are likely to fail. 
 
 The second example of a successful implementation of a PMTCT strategy is 
offered by Côte D’Ivoire and it illustrates how to integrate PMTCT training for 
health service providers in the curricula of training institutions in order to allow 
health care workers to take proper care of pregnant women, and in this way, battle 
HIV transmission from mother-to-child (Ministère de la Santé et de l’Hygiène 
Publique [58], Ministère de la lutte contre le SIDA [59]).  
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It is widely acknowledged that information, education and training are critical 
components of any programme targeted at preventing mother to child HIV 
transmission. Côte D’Ivoire has been successful in promoting these components, 
and therefore, the strategies adopted in this country also offer considerable scope 
for replication. Whilst the lessons learned from the experience of Côte D’Ivoire 
may be useful for many countries, we believe they are particularly relevant to 
those countries which the DEA analysis identified as having Côte D’Ivoire as a 
benchmark. These countries include, among others, Benin, Burkina Faso, 
Equatorial Guinea, El Salvador, Ghana, Honduras and Senegal. 
 
Côte D’Ivoire experience, which is discussed in further detail in Family Health 
International [54], can help these countries develop and implement HIV 
sustainable PMTCT approaches grounded on a participatory process and targeted 
at promoting long-term quality training in health care training institutions. In fact, 
the process followed by Côte D’Ivoire, which consists of several steps, can work 
as a guide for other countries. The first step consists of carrying out a needs 
assessment to evaluate existing PMTCT pre-service and in-service training 
materials for health care workers and to determine how best to integrate PMTCT 
into pre-service and in-service health training curricula. Once this assessment has 
been conducted, good practice consists of holding a stakeholders meeting to share 
the findings and to create a steering committee to oversee, monitor progress and 
provide leadership in the development and standardisation of PMTCT in-service 
and pre-service training initiatives. It is then the responsibility of this steering 
committee to mobilise trainers and opinion leaders, to involve them in the 
PMTCT roll-out through a participatory process, and to sensitise them to the 
importance of the prevention plan and training needs. Once universities and 
training institutions are sensitised, the next step consists of developing PMTCT 
training materials for service providers. These initiatives, together with the 
creation of a pool of expert trainers representative of all the pre-service and in-
service institutions, can assist countries in providing over the course of time a 
critical mass of health care professionals capable of mastering PMTCT practices 
throughout nations. 
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These two examples illustrate that DEA has strong potential to contribute to 
performance improvement in the context of PMTCT if used with formative 
purposes. By using DEA, policy makers and health care managers can identify 
which countries have been most successful in using the limited resources 
available to prevent the transmission of HIV from mothers to children. However, 
the identification of best practice is only the first step in the process. It is then 
fundamental that these practices are carefully analysed and documented in order 
to be disseminated and replicated. 
 
Although our empirical analysis covers only a single year and a limited number of 
countries, it is important to emphasise that the results achieved still provide useful 
information for policy making, which can contribute to the development of 
programmes aimed at improving the efficiency of PMTCT. 
 
 
4 – Conclusion 
 
In spite of the remarkable progress that has been made in recent years in battling 
the HIV/AIDS epidemic, this disease still poses huge challenges for individuals, 
households and nations. It is estimated that more than 1,000 children are newly 
infected with HIV every day, and of these more than half will die as a result of 
AIDS because of a lack of access to HIV treatment [1]. Over 90 percent of the 
children living with HIV were infected through vertical transmission from mother 
to the baby during pregnancy, delivery or breastfeeding. Considering that there is 
compelling evidence that appropriate prevention and care can reduce the rate of 
these transmissions significantly, it is imperative that nations ensure that this 
prevention and care reaches all pregnant women and children in need and that the 
resources are used as efficiently as possible.  
 
In the academic literature there have been important contributions exploring the 
efficiency and cost-effectiveness of different HIV prevention programmes, 
including mother-to-child transmission. Most of these contributions have, 
however, been narrowed to a small region, a single country or parts of it, and have 
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tended to rely on the use of a set of individual indicators detailing different 
aspects of service delivery. In this paper, we have explored the potential of using 
DEA to complement the existing literature in the area. To this effect we have 
proposed a model, using data from 2008, with five inputs and four outputs to 
compare the efficiency of 52 low- and middle-income countries in preventing 
mother-to-child HIV transmission.  
 
Despite the exploratory nature of the research, there are some important empirical 
findings from our study. In particular, we found wide variation in terms of the 
efficiency of service provision across nations, indicating that some countries have 
been considerably more efficient in allocating resources to preventing HIV 
transmission from mother-to-child than others. This variation ought to be 
investigated as our results suggest that if all countries were using their resources 
efficiently, the level of service provision could increase by around 40 percent. 
Considering that the analysis reported in this paper also allows the identification 
of suitable learning peers for each nation, as well as targets for performance 
improvement, we believe it can be an important catalyst for a deeper formative 
assessment aimed at identifying the causes of poor performance, exploring the 
practices of the best performers; and based on this assessment to develop sound 
strategies for HIV prevention improvement. 
 
The formative implementation of DEA in this context, however, faces some 
challenges. One of the most relevant is, perhaps, the lack of availability of data  
and/or poor data quality. There are many countries for which there is no data, and 
even when data exists it does not cover all the important variables, does not cover 
more than a year, or does not guarantee accuracy of information. Data 
unavailability might prevent the specification of appropriate models or might 
prevent the inclusion of countries in the analysis which could eventually change 
the efficiency frontier. As emphasised by Pedraja-Chaparro et al. [60], a shortage 
of observations can bias the DEA results as some parts of the feasible activity 
domain may not be properly modelled. When this happens, some countries may 
be regarded as efficient simply because there are no peers with which to compare 
them. Furthermore, when no panel data exists, it is not possible to perform 
dynamic assessments targeted at analysing eventual changes in the performance of 
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nations over time. In turn, poor data quality can also significantly impact the DEA 
results. As the technique relies on outlier DMUs to construct an efficient frontier, 
a single error of measurement can lead to a significant adjustment in the estimated 
frontier. In order to detect particularly influential countries, and therefore, those 
countries that might require careful scrutiny of the data to prevent measurement 
errors, we can use the super efficiency measure as suggested by Anderson and 
Petersen [61], or we can count the number of times an efficient country appears in 
the peer group of inefficient countries as indicated by Pedraja-Chapparo et al. 
[60]. When doubts exist regarding the quality of the data, the analyst or decision 
maker can also carry out a careful sensitivity analysis in order to construct data 
ranges within which results remain unchanged.  
 
Another important challenge relates to the need to include weight restrictions in 
the models. In developing DEA models to assess the efficiency of countries in 
implementing particular HIV prevention policies it is important to decide whether 
it is acceptable to allow full flexibility in the choice of input and output weights.  
Whilst several approaches to define weight restrictions exist, the specification of 
appropriate weight restrictions can be a very challenging task. Research on how to 
express weight restrictions that are economically valid and that derive from the 
preferences of the stakeholders is very scarce. 
 
In the particular context under study, it is our belief that an early involvement of 
the key stakeholders in the process, together with the procedures suggested above 
to address data quality issues, are fundamental aspects to consider to strengthen 
the DEA analysis and allow firmer policy lessons. Furthermore, whenever data 
permits, it can be insightful to form clusters with countries sharing socio-cultural, 
political and economic commonalities and perform disaggregate analyses for 
these clusters. 
 
It is important to emphasise that despite the fact that the successful application of 
DEA can be a challenge, DEA has strong potential to contribute to performance 
improvement in this context. In particular, DEA is well suited to complement 
efficiency analyses undertaken by means of other methodologies. 
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In conclusion, we believe that DEA is a strong analytical technique upon which to 
build and which can play an important role in the development of efficient HIV 
prevention interventions. This paper has discussed some of the insights that derive 
from the use of DEA in this particular context. However, one of the premises of 
the authors of this paper is that DEA has to be broadened in order to contribute to 
performance improvement in practice. One of the main aspects of this broadening 
relates to the need to move away from the ‘black box’ type of evaluation, by 
incorporating the DEA exercise into case studies and context-driven research 
projects in order to facilitate the development of appropriate models and the 
implementation of the results in practice. Unless the results of these models are 
taken into consideration by decision makers and incorporated into the policy 
making process, their purposes are not served. Further research is being carried 
out by the authors in order to meet these objectives. 
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Appendix 
 
Multiplier version of the DEA model used in the analysis (includes one weight 
restriction) 
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Where E0 is the relative efficiency of DMU0, Xi0 is the quantity of Input i used by 
DMU0 (with i =1 ... 5) and Yr0  the quantity of Output r produced by DMU0 (with r 
= 1, ..., 4), Vi is the weight attributed to Input i, Ur is the weight attributed to 
Output r, and w0 is the scale variable for DMU0.  
 
